In addition to the finding of MC4R’s involvement in attenuating AAA in mice, we found that α-MSH treatment could also inhibit Ang II-induced AAA incidence, which was accompanied by the reduction in inflammatory-related-genes expressions in the aortic lesion. This evidence concerns the gene MC4R and triple-A syndrome.